Show simple item record

dc.contributor.authorHuerga, H
dc.contributor.authorMueller, Y
dc.contributor.authorFerlazzo, G
dc.contributor.authorMpala, Q
dc.contributor.authorBevilacqua, P
dc.contributor.authorVasquez, B
dc.contributor.authorNoël Mekiedje, C
dc.contributor.authorOuattara, A
dc.contributor.authorMchunu, G
dc.contributor.authorWeyenga, HO
dc.contributor.authorVaraine, F
dc.contributor.authorBonnet, M
dc.date.accessioned2016-06-27T18:21:44Z
dc.date.available2016-06-27T18:21:44Z
dc.date.issued2016-04-01en
dc.identifier.citationImplementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings. 2016, 71 (4):e89-95 J. Acquir. Immune Defic. Syndr.en
dc.identifier.issn1944-7884en
dc.identifier.pmid26910386en
dc.identifier.doi10.1097/QAI.0000000000000895en
dc.identifier.urihttp://hdl.handle.net/10144/614839
dc.description.abstractThe tuberculin skin test (TST) can be used to identify HIV-infected people who would benefit the most from long-term isoniazid preventive therapy (IPT). However, in resource-constrained settings, implementation of the TST can be challenging. The objectives of this study were to assess the feasibility of implementing the TST for IPT initiation and to estimate the proportion of TST-positive incidence among HIV-positive patients in 2 high tuberculosis and HIV burden settings.
dc.language.isoenen
dc.publisherLippincott Williams & Wilkinsen
dc.rightsArchived with thanks to Journal of Acquired Immune Deficiency Syndromesen
dc.titleImplementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settingsen
dc.typeArticleen
dc.identifier.journalJournal of Acquired Immune Deficiency Syndromesen
dc.internal.reviewer-noteJAIDS foir April 2017en
refterms.dateFOA2019-03-04T12:47:44Z
html.description.abstractThe tuberculin skin test (TST) can be used to identify HIV-infected people who would benefit the most from long-term isoniazid preventive therapy (IPT). However, in resource-constrained settings, implementation of the TST can be challenging. The objectives of this study were to assess the feasibility of implementing the TST for IPT initiation and to estimate the proportion of TST-positive incidence among HIV-positive patients in 2 high tuberculosis and HIV burden settings.


Files in this item

Thumbnail
Name:
Huerga et al - 2016 - Feasibility ...
Size:
332.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record